Home > Insider Trading > Filing (0001127602-21-011860)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1412221	M Thomas Moriarty	One Cvs Drive Woonsocket RI 02895	Evp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-19	49,211	$74.15	18,226	No	4	S	Indirect	By GRAT

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By GRAT

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Restricted)	12,778	Direct
Stock Unit	45,455	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$74.29	2015-04-01	2021-04-01	62,943	62,943	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	51,361	51,361	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	71,696	71,696	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	125,224	125,224	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	145,959	145,959	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	202,007	202,007	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	197,116	197,116	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-01	62,943	62,943	Direct
2022-04-01	51,361	51,361	Direct
2023-04-01	71,696	71,696	Direct
2024-04-03	125,224	125,224	Direct
2025-04-01	145,959	145,959	Direct
2029-04-01	202,007	202,007	Direct
2030-04-01	197,116	197,116	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.00 and $74.58 per share.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Option becomes exercisable in four equal annual installments, commencing 4/1/2021.